Compare SPNT & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SPNT | RXRX |
|---|---|---|
| Founded | 2011 | 2013 |
| Country | Bermuda | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.2B |
| IPO Year | N/A | 2021 |
| Metric | SPNT | RXRX |
|---|---|---|
| Price | $21.65 | $4.90 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 4 |
| Target Price | ★ $24.00 | $7.25 |
| AVG Volume (30 Days) | 488.4K | ★ 25.7M |
| Earning Date | 10-30-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.45 | N/A |
| Revenue | ★ $2,859,100,000.00 | $43,689,000.00 |
| Revenue This Year | $0.89 | $7.79 |
| Revenue Next Year | $6.87 | $27.32 |
| P/E Ratio | $14.67 | ★ N/A |
| Revenue Growth | ★ 6.92 | N/A |
| 52 Week Low | $13.26 | $3.79 |
| 52 Week High | $21.77 | $12.36 |
| Indicator | SPNT | RXRX |
|---|---|---|
| Relative Strength Index (RSI) | 75.31 | 54.61 |
| Support Level | $19.65 | $4.32 |
| Resistance Level | $21.33 | $4.59 |
| Average True Range (ATR) | 0.52 | 0.28 |
| MACD | 0.09 | 0.10 |
| Stochastic Oscillator | 99.51 | 97.35 |
SiriusPoint Ltd provides property and casualty reinsurance coverage to insurance and reinsurance companies in the United States, Canada, Bermuda, the United Kingdom, and Europe. The company operates through two operating segments: Reinsurance and Insurance & Services. The company's product portfolio consists of reinsurance contracts for property insurance including both residential and commercial properties, workers' compensation, personal automobile, businesses' general liability insurance, professional liability insurance to protect professional advisors and service providers, agriculture insurance, and mortgage insurance. The majority of the revenue is generated from its Insurance & Services segment.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.